Premium Nahrungsergänzungsmittel | artgerecht

Xenobiotic Clearance Test – Liver Detoxification

The xenobiotic clearance test evaluates how efficiently the liver metabolises and eliminates foreign substances. It provides key insights into the body's detoxification capacity.

Regular tips about health Regular tips about health

Things worth knowing about "Xenobiotic clearance test"

The xenobiotic clearance test evaluates how efficiently the liver metabolises and eliminates foreign substances. It provides key insights into the body's detoxification capacity.

What is the Xenobiotic Clearance Test?

The xenobiotic clearance test is a diagnostic procedure used to assess the ability of the human body – primarily the liver – to metabolise and eliminate xenobiotics. Xenobiotics are chemical substances that are foreign to the body and not naturally part of its metabolic pathways. Common examples include medications, environmental pollutants, pesticides, and industrial chemicals.

Clearance refers to the volume of blood or plasma completely cleared of a given substance per unit of time. This test provides valuable information about an individual's detoxification capacity and hepatic metabolic function.

How Does the Test Work?

During a xenobiotic clearance test, the patient is given a defined, typically very small dose of a test substance. Blood or urine samples are then collected at set intervals to measure how quickly and completely the substance is eliminated from the body.

Commonly used test substances include:

Caffeine: A well-tolerated marker reflecting the activity of the liver enzyme CYP1A2.
Antipyrine (phenazone): A classic marker for overall hepatic oxidative capacity.
Lidocaine (MEGX test): Assesses liver function by measuring the metabolite monoethylglycinexylidide.

When is the Test Used?

The xenobiotic clearance test is applied in a variety of clinical and research settings:

Assessment of liver function in chronic liver diseases such as cirrhosis or hepatitis
Pre-transplant evaluation for liver transplantation
Individualised drug dose adjustment in patients with impaired liver or kidney function
Environmental medicine investigations for toxic substance exposure
Pharmacological and toxicological research

Which Enzymes Are Involved?

The detoxification of xenobiotics in the liver occurs mainly in two phases:

Phase I Reactions

In Phase I, xenobiotics are chemically modified through oxidation, reduction, or hydrolysis. The key enzymes involved are the cytochrome P450 enzymes (CYP enzymes), particularly CYP1A2, CYP2D6, CYP2C9, and CYP3A4. These reactions make the substances more reactive and accessible for further processing.

Phase II Reactions

In Phase II, the modified substances are conjugated with endogenous molecules such as glutathione, glucuronic acid, or sulfate, making them more water-soluble and easier to excrete. Important enzymes in this phase include glutathione S-transferases, UDP-glucuronosyltransferases, and sulfotransferases.

Interpretation of Results

A reduced clearance indicates impaired detoxification capacity and may result from:

Chronic liver damage (e.g., fibrosis, cirrhosis, fatty liver disease)
Genetically determined enzyme variants (polymorphisms)
Concurrent use of medications that inhibit or induce metabolic enzymes
Malnutrition or micronutrient deficiencies

An increased clearance may indicate enzyme induction, for example due to certain medications, smoking, or alcohol consumption.

Comparison with Standard Liver Function Tests

Unlike standard liver markers such as AST, ALT, or bilirubin, which primarily reflect cell damage, the xenobiotic clearance test measures the functional metabolic capacity of the liver. It is therefore considered a dynamic and sensitive indicator of true hepatic detoxification performance.

References

Klotz, U. (2007): Clinical pharmacokinetics of antipyrine – revisited. In: Clinical Pharmacokinetics, 46(10), 815–823.
Pugh, R.N. et al. (1973): Transection of the oesophagus for bleeding oesophageal varices. In: British Journal of Surgery, 60(8), 646–649.
Zanger, U.M. & Schwab, M. (2013): Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. In: Pharmacology & Therapeutics, 138(1), 103–141.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.